Everstone Capital Acquires Controlling Stake in Softgel Healthcare

Everstone Acquires Controlling Stake in Calibre

August 31, 2021

Manufacturing

Everstone Capital (Everstone Group) purchased a controlling stake in Calibre, a Mumbai-headquartered specialty ingredients manufacturer focused on iodine derivatives, persulfates and perchlorates. The investment will support Calibre's transformation from a family-owned business into a global player across pharmaceutical, nutritional and personal care end markets.

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.

HUTCHMED Divests 45% Stake in Shanghai Hutchison Pharmaceuticals to GP Health Service Capital and Shanghai Pharmaceuticals Holding

January 3, 2025

Pharmaceuticals

HUTCHMED agreed to sell a 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for about US$608 million in cash to GP Health Service Capital Co. and Shanghai Pharmaceuticals Holding. The divestment allows HUTCHMED to reallocate capital to its core oncology and ATTC (antibody-targeted therapy conjugate) pipeline and accelerate its path to profitability.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

SHS Capital and ING Corporate Investments Acquire Majority Stake in CAM Bioceramics

July 7, 2023

Medical Devices

German healthcare specialist investor SHS Capital, together with ING Corporate Investments and several co-investors, acquired a majority stake in CAM Bioceramics B.V., a Leiden-based contract development and manufacturing organization (CDMO) for orthobiologic calcium phosphate solutions. Existing owners rolled over a significant stake and management remains in place; the transaction aims to strengthen the business and accelerate investment in people, capabilities and customer partnerships to drive growth.

Ontario Teachers' Acquires Majority Stake in Sahyadri Hospitals from Everstone

August 17, 2022

Healthcare Services

Ontario Teachers' Pension Plan Board's Private Capital team has agreed to acquire a significant majority stake in Sahyadri Hospitals Group from Everstone Group. Sahyadri is a Pune-headquartered multi-specialty hospital chain with c. 8 hospitals and ~900 operating beds (2,000 clinicians and 2,600 support staff reported) and the deal is expected to close in Q4 2022; founders and management will retain minority stakes.